Heart Disease and Hypertension OPD Management: A Clinical Guide for Indian Doctors

Cardiovascular disease is now India's leading cause of mortality. As a clinic doctor, you are the first point of contact for hypertension screening, medication initiation, and chronic cardiac follow-up. This guide covers the essential OPD protocols for managing the most common cardiac conditions.

Cardiovascular Disease Burden in India

India faces a unique CV disease profile: earlier onset (by a decade compared to Western populations), higher proportion of non-obese patients with metabolic risk, and very high rates of uncontrolled hypertension despite treatment. The Indian Heart Association estimates that 50% of Indians with hypertension do not know they have it, and of those who do know, only 12–15% have controlled BP.

Hypertension: Diagnosis and OPD Management

Diagnosis Thresholds (2024 ESC/Indian Guidelines)

BP ≥140/90 mmHg on two separate visits = Grade 1 Hypertension. BP ≥160/100 = Grade 2. Measure in both arms on first visit; use the higher reading arm for future measurements.

White-coat hypertension is common in Indian patients. If clinic BP is elevated but patient denies symptoms, confirm with home BP monitoring (average of ≥12 readings over 3–7 days) before initiating medication.

First-Line Medication Choices

BP Targets

• General adult: <130/80 mmHg if tolerated
• Age ≥65 years: <140/80 (avoid over-treatment — fall and syncope risk)
• Diabetes: <130/80 mmHg
• CKD with proteinuria: <125/75 mmHg

Ischaemic Heart Disease in OPD

Stable Angina: OPD Management Protocol

Patients with diagnosed stable IHD attending your OPD for follow-up need structured assessment at every visit: symptom frequency, exercise tolerance, BP and HR, and medication adherence review.

Essential medications for stable IHD:

• Aspirin 75–100mg OD — lifelong unless contraindicated
• Statin — Rosuvastatin 20–40mg or Atorvastatin 40–80mg. Target LDL <55 mg/dL in high-risk patients (post-MI, diabetes + IHD)
• Beta-blocker — Metoprolol succinate 25–100mg OD (rate control, anti-anginal). Target resting HR 55–65 bpm
• ACE inhibitor or ARB — especially if EF <40%, diabetes, or CKD
• Sublingual GTN — every patient should have it and know when to use it

Heart Failure: Recognition and Outpatient Management

Clinical Recognition in OPD

Heart failure with reduced ejection fraction (HFrEF, EF <40%) and heart failure with preserved ejection fraction (HFpEF, EF ≥50%) require different management but share similar symptoms: breathlessness on exertion, orthopnoea, ankle oedema, fatigue.

NYHA functional classification for OPD monitoring:

• Class I: No symptoms with ordinary activity — managed in OPD
• Class II: Slight limitation with ordinary activity — OPD + diuretic optimisation
• Class III: Marked limitation with less-than-ordinary activity — OPD + specialist co-management
• Class IV: Symptoms at rest — refer for hospitalisation/urgent cardiology

HFrEF Treatment (Guideline-Directed Medical Therapy)

The four pillars of HFrEF treatment (all have proven mortality benefit):

1. ACE inhibitor/ARB or ARNI (Sacubitril-Valsartan if affordable) — start low, titrate to maximum tolerated dose
2. Beta-blocker — Carvedilol 3.125mg BD, titrate slowly. Do NOT start during acute decompensation
3. Mineralocorticoid receptor antagonist — Spironolactone 25mg OD (monitor K+ and creatinine)
4. SGLT2 inhibitor — Dapagliflozin 10mg OD (now indicated in HFrEF regardless of diabetes)

Indian-Specific CV Risk Factors

Screen all patients >30 years for these at annual well visits:

• Dyslipidaemia: Fasting lipid profile. Indians commonly have low HDL and high triglycerides even with normal LDL — this pattern is high-risk
• Diabetes and pre-diabetes: HbA1c + fasting glucose. 50% of Indian T2DM patients are undiagnosed
• Central obesity: Waist circumference >90/80 cm (M/F) even with normal BMI
• Tobacco: Include smokeless tobacco (gutka, khaini) — heavily underreported and significantly increases CV risk
• Sleep apnoea: STOP-BANG questionnaire for all hypertensive patients not responding to 2+ drugs

When to Refer: Cardiology Red Flags

Lifestyle Counselling for Indian Patients

Effective 60-second counselling points that Indian patients respond to:

• Salt reduction: "No extra salt at table, no pickles, no papads" — more actionable than "reduce sodium to 2g/day"
• Oil: Limit to 3–4 tsp per person per day. Rice bran or mustard oil preferred over coconut or palm
• Exercise: 30 min brisk walking 5 days/week. Yoga and pranayama have evidence for BP reduction in Indians
• Alcohol: Any amount increases BP. For patients who drink, reduction by 50% is an achievable first goal
• Stress: Occupational and financial stress are major unaddressed CV risk factors in Indian patients — ask directly

Clinic software with built-in chronic disease follow-up reminders helps you ensure hypertensive patients don't fall through the cracks. See how CliniqFlo's EMR tracks BP trends across visits →